Association of Interleukin-6-572C/G Gene Polymorphism and Serum or Cerebrospinal Fluid Interleukin-6 Level with Enterovirus 71 Encephalitis in Chinese Han Patients with Hand, Foot, and Mouth Disease
- 319 Downloads
Interleukin-6 (IL-6), as one of pro-inflammatory cytokines, plays a key role in Enterovirus 71 (EV71) encephalitis. We investigated the association of IL-6-572C/G polymorphism and serum or cerebrospinal fluid (CSF) IL-6 level with EV71 encephalitis in patients with hand, foot, and mouth disease (HFMD). This study was carried out in 59 Chinese Han patients with EV71 encephalitis, 128 EV71-related HFMD without complications, and 232 controls. The IL-6-572C/G polymorphism was detected by polymerase chain reaction-restricted fragment length polymorphism gene analysis. Serum or CSF IL-6 levels were determined using a commercial enzyme-linked immunosorbent assay. The patients with EV71 encephalitis had a higher frequency of IL-6-572GG/GC genotype compared to the patients with EV71-related HFMD without encephalitis complications (40.7 vs. 15.6 %, odds ratio (OR) = 3.70, 95 % confidence interval (CI) = 1.83–7.50, p = 0.001). Similarly, the frequency of IL-6-572 G allele among the patients with EV71 encephalitis was also higher than that of patients with EV71-related HFMD without encephalitis complications (23.7 vs. 8.6 %, OR = 3.31, 95 % CI = 1.80–6.08, p < 0.001). Serum IL-6 levels in G carries (CG + GG) (195.1 ± 11.8 pg/ml) elevated significantly compared to CC homozygotes (167.7 ± 6.7 pg/ml) in EV71-infected patients (p < 0.001), but no significant differences were observed in CSF IL-6 levels among different genotypes in patients with EV71 encephalitis. Furthermore, G carriers (GG + GC) (10.6 ± 1.29 mg/l) had significantly higher blood CRP levels compared to CC homozygotes (9.31 ± 1.93 mg/l) in patients with EV71 encephalitis (p = 0.005). These findings suggested that IL-6-572 G allele was significantly associated with the susceptibility to EV71 encephalitis in Chinese Han patients, and IL-6-572 G allele might elevate the risk to EV71 encephalitis.
KEY WORDSenterovirus 71 encephalitis interleukin-6 polymorphism
Financial support for this project was supported by grants from the Natural Science of China (no. 31171212), and there are no ethical/legal conflicts involved in the article.
Conflict of Interest
The authors declared no competing of interests.
- 9.Li, L., Y. He, H. Yang, J. Zhu, X. Xu, J. Dong, Y. Zhu, and Q. Jin. 2005. Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People’s Republic of China. Journal of Clinical Microbiology 43: 3835–3839.PubMedCentralPubMedCrossRefGoogle Scholar
- 12.Zhang, Y., H. Liu, L. Wang, F. Yang, Y. Hu, X. Ren, G. Li, Y. Yang, S. Sun, Y. Li, X. Chen, X. Li, and Q. Jin. 2013. Comparative study of the cytokine/chemokine response in children with differing disease severity in enterovirus 71-induced hand, foot, and mouth disease. PloS One 8: e67430.PubMedCentralPubMedCrossRefGoogle Scholar
- 15.Lehtimäki, T., P. Ojala, R. Rontu, S. Goebeler, P.J. Karhunen, M. Jylhä, K. Mattila, S. Metso, H. Jokela, M. Nikkilä, E. Wuolijoki, A. Hervonen, and M. Hurme. 2005. Interleukin-6 modulates plasma cholesterol and C-reactive protein concentrations in nonagenarians. Journal of the American Geriatrics Society 53: 1552–1558.PubMedCrossRefGoogle Scholar
- 17.Yan, J., J. Liu, C.Y. Lin, A.N. Anzgene, P.A. Csurhes, M.P. Pender, P.A. McCombe, and J.M. Greer. 2012. Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis. International Journal of Molecular Sciences 13: 13667–13679.PubMedCentralPubMedCrossRefGoogle Scholar
- 18.Sen, A., S.K. Paine, I.H. Chowdhury, A. Mukherjee, S. Choudhuri, A. Saha, L.K. Mandal, and B. Bhattacharya. 2011. Impact of interleukin-6 promoter polymorphism and serum interleukin-6 level on the acute inflammation and neovascularization stages of patients with Eales’ disease. Molecular Vision 17: 2552–2563.PubMedCentralPubMedGoogle Scholar
- 19.Chiaretti, A., S. Pulitanò, G. Barone, P. Ferrara, V. Romano, D. Capozzi, and R. Riccardi. 2013. IL-1 β and IL-6 upregulation in children with H1N1 influenza virus infection. Mediators of Inflammation 495848.Google Scholar
- 20.Levitz, R., R. Wattier, P. Phillips, A. Solomon, J. Lawler, I. Lazar, C. Weibel, and J.S. Kahn. 2012. Induction of IL-6 and CCL5 (RANTES) in human respiratory epithelial (A549) cells by clinical isolates of respiratory syncytial virus is strain specific. Virology Journal 9: 190.PubMedCentralPubMedCrossRefGoogle Scholar
- 21.Fishman, D., G. Faulds, R. Jeffery, V. Mohamed-Ali, J.S. Yudkin, S. Humphries, and P. Woo. 1998. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. The Journal of Clinical Investigation 102: 1369–1376.PubMedCentralPubMedCrossRefGoogle Scholar
- 22.Hulkkonen, J., M. Pertovaara, J. Antonen, A. Pasternack, and M. Hurme. 2001. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren’s syndrome and correlate with the clinical manifestations of the disease. Rheumatology (Oxford, England) 40: 656–661.CrossRefGoogle Scholar
- 23.Patel, J.A., S. Nair, E.E. Ochoa, R. Huda, N.J. Roberts, and T. Chonmaitree. 2010. Interleukin-6−174 and tumor necrosis factor α−308 polymorphisms enhance cytokine production by human macrophages exposed to respiratory viruses. Journal of Interferon & Cytokine Research 30: 917–921.CrossRefGoogle Scholar
- 26.Boiardi, L., B. Casali, E. Farnetti, N. Pipitone, D. Nicoli, F. Cantini, P. Macchioni, G. Bajocchi, M.G. Catanoso, L. Pulsatelli, D. Consonni, and C. Salvarani. 2006. Relationship between interleukin 6 promoter polymorphism at position −174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica. The Journal of Rheumatology 33: 703–708.PubMedGoogle Scholar
- 27.Bennermo, M., M. Nordin, P. Lundman, S. Boqvist, C. Held, A. Samnegård, C.G. Ericsson, A. Silveira, A. Hamsten, M.M. Nastase, and P. Tornvall. 2011. Genetic and environmental influences on the plasma interleukin-6 concentration in patients with a recent myocardial infarction: a case-control study. Journal of Interferon & Cytokine Research 31: 259–264.CrossRefGoogle Scholar